All the news Showing 10 of 83 articles from: Ns5A inhibitorsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Impact of Food and Antacids on Levels of Ledipasvir and Sofosbuvir NATAP / 28 May 2014 AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C AbbVie press release / 23 April 2014 Merck Announces Results from Studies Evaluating Investigational Hepatitis C Treatments, MK-5172 and MK-8742, in Treatment-Naïve Patients with Genotype 1 Infection Merck press release / 11 April 2014 Gilead Announces U.S. FDA Priority Review Designation for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Chronic Hepatitis C Genotype 1 Infection Gilead press release / 07 April 2014 Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C Bristol-Myers Squibb press release / 07 April 2014 European Medicines Agency advises on compassionate use of a new combination therapy for chronic hepatitis C European Medicines Agency / 21 February 2014 Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C Gilead press release / 11 February 2014 AbbVie Completes Largest Phase III Program of an All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C Genotype 1 AbbVie press release / 31 January 2014 Bristol-Myers Ties Hepatitis C Success to Gilead’s Pill Bloomberg / 14 January 2014 Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones Achillion press release / 14 January 2014 ← Prev1...34567...9Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive